Healthcare & Life Sciences
Visirna Therapeutics
Germany
seed
seed
Stage
1
Investors
About
Visirna Therapeutics develops RNA-targeted therapies to treat neurodegenerative and other central nervous system diseases by modulating RNA splicing and expression.
Explore Visirna Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.